Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic Acid in Free Gingival Graft Healing
NCT05990049Phase 3Unknown
- Sponsor
- University of Zagreb
- Start
- Mar 2023
- Primary completion
- Jan 2024
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of cross-linked hyaluronic acid in gingival recession (2 arms), sponsored by University of Zagreb. Primary endpoints: Keratinized tissue gain at 6 months and Shrinkage of the graft at 6 months. Status: unknown.
02
Drugs
cross-linked hyaluronic acid
03
Conditions
gingival recession
Beyond the preview
Go deeper on NCT05990049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05990049.